Skip to main content

Table 2 Distribution of risk attitude, socioeconomic factors, duration of treatment and comorbidity, n = 6396*

From: Associations between patients’ risk attitude and their adherence to statin treatment – a population based questionnaire and register study

  N (%)
Risk attitude, Financial  
 Risk-averse 5188 (81.1)
 Risk-neutral 512 (8.0)
 Risk-seeking 696 (10.9)
Risk attitude, health: Focus on healthy behaviour  
 Risk-averse 4153 (64.9)
 Risk-neutral 1436 (22.5)
 Risk-seeking 807 (12.6)
Risk attitude, health: Count on symptoms passing  
 Risk-averse 776 (12.1)
 Risk-neutral 591 (9.2)
 Risk-seeking 5029 (78.6)
Risk attitude, health: Preference for GP contact regarding my health  
 Risk-averse 3572 (55.9)
 Risk-neutral 1244 (19.5)
 Risk-seeking 1580 (24.7)
Gender  
 Male 3544 (55.4)
 Female 2852 (44.5)
Age (years)  
 20–39 70 (1.1)
 40–59 1781 (27.9)
 60–79 4545 (71.1)
Income  
 Low (1st quartile) 957 (15.0)
 Medium (2nd + 3rd quartile) 3504 (54.8)
 High (4th quartile) 1933 (30.2)
Highest attained educational level (years)  
  < 10 1757 (27.9)
 10–12 2992 (47.5)
  > 12 1551 (24.6)
Cohabitation status  
 Single 1399 (21.9)
 Married/cohabiting 4995 (78.1)
Labour market status  
 Working 2574 (40.2)
 Retirement pension 3193 (49.9)
 Not in the workforce 629 (9.8)
Duration of statin treatment  
  < 1 year 539 (8.4)
 1–2 years 547 (8.6)
 2–5 years 3089 (48.3)
 5–10 years 1526 (23.9)
  < 10 years 695 (10.9)
Comorbidity  
 CVD  
 No CVD 5340 (83.5)
 CVD 1056 (16.5)
Charlson  
 None 3593 (55.6)
 1 1491 (23.8)
  ≥ 2 1289 (20.6)
  1. *Up to 1.5 % missings in registers
\